Full Text View
Tabular View
No Study Results Posted
Related Studies
Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes
This study has been completed.
Study NCT00645840   Information provided by University of Texas Southwestern Medical Center

First Received on March 25, 2008.   Last Updated on June 12, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 1 Diabetes Mellitus
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 1
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Interventions listed in this trial
Anakinra
Additional drug interventions recognized in this trial
Anti-Inflammatory Agents
Interleukin 1 Receptor Antagonist Protein
More general drug interventions related to this trial
Antirheumatic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Texas Southwestern Medical Center
Children's Medical Center Dallas


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services